Medifast reported a $17.5 million Q3 2026 loss driven by restructuring, while coach productivity rose 54% and management ...
A new study suggests that women using menopause hormone therapy alongside GLP-1 medications like Wegovy may experience greater weight loss.
Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended ...
Petrelintide, an amylin agonist medication, may support weight loss with fewer gastrointestinal side effects than GLP-1 drugs, according to early research.
Trisha Yearwood has been candid about dieting and weight loss over the years. Here’s everything to know about Trisha Yearwood ...
Its leading investigational drug demonstrated relatively high levels of weight loss in a late-stage clinical trial.
The Menopause Society noted that middle-aged women commonly experience weight gain resulting from menopause, and have turned to GLP-1 drugs for help. About 1 in 5 women 50 to 64 are or have used a GLP ...
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results